Iscador Qu for chronic hepatitis C: an exploratory study
- 31 March 2001
- journal article
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 9 (1) , 12-16
- https://doi.org/10.1054/ctim.2000.0408
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Toxicity of a Standardized Mistletoe Extract in Immunocompromised and Healthy IndividualsClinical Journal of Sport Medicine, 1999
- Global surveillance and control of hepatitis CJournal of Viral Hepatitis, 1999
- Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in TaiwanJournal of Gastroenterology and Hepatology, 1998
- Anticarcinogenic and antimetastatic activity of IscadorAnti-Cancer Drugs, 1997
- Reliability of polymerase chain reaction for detection of hepatitis C virusThe Lancet, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- AViscum album oligosaccharide activating human natural cytotoxicity is an interferon γ inducerCancer Immunology, Immunotherapy, 1990
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- The in vitro activity of lectin I from mistletoe (ML I) and its isolated A and B chains on functions ofmacrophages and polymorphonuclear cellsImmunobiology, 1985